-
A Mature Capital Structure Positions Bio-IT Startups For Success
Dec 6, 2018, 11:45 AM by Michael CroftFull storyBio-IT World Contributed Commentary | By establishing a mature capital structure reflecting a healthy balance of both equity and debt, early-stage bio-IT companies can project long-term strength and vision that helps to favorably position them with their stakeholders.
-
Industry Leaders Join Forces to Discuss Optimizing eConsent for Patient Centricity
Dec 6, 2018, 09:03 AM by Michael CroftPLYMOUTH MEETING, PA - Dec 6, 2018 - Clinical research and technology leaders from across the industry will share their data and expertise at an upcoming webinar hosted by CRF Health, a CRF Bracket company, to discuss how to improve patient centricity through electronic informed consent (eConsent)Full story -
Melissa Unlocks Insight and Revenue with Breakthrough AI Tools for Clinics and Research Centers
Dec 5, 2018, 14:45 PM by Michael CroftRANCHO SANTA MARGARITA, CA, UNITED STATES - Dec 4, 2018 - Melissa Unlocks Insight and Revenue with Breakthrough AI Tools for Clinics and Research CentersCutting Edge Data Quality Transforms Real-World Clinical Data into aFuture-Proofed, Research-Ready Data Goldmine for Better Patient CareMelissa, a leading provider of global contact data quality and identity verification solutions, today announced advanced artificial intelligence (AI) solutions that combine machine reasoning, natural language processing, and machine learning to tackle one of healthcare's biggest problems: the time and cost of data harmonization and integrationFull story -
Equus Compute Solutions Announces Release of G2660 2U 2xGPU Server
Dec 5, 2018, 13:47 PM by Michael CroftEDINA, MN - Dec 5, 2018 - Equus Compute Solutions announces the release of its new G2660 2U 2xGPU server, ideal for artificial intelligence and deep learning environmentsFull story -
Sekisui XenoTech Announces Creation of Scientific Advisory Board (SAB)
Dec 5, 2018, 11:11 AM by Michael CroftKANSAS CITY, KS, UNITED STATES - Dec 5, 2018 - Sekisui XenoTech has created a Scientific Advisory Board (SAB) of renowned scientists and thought leaders in the pharmaceutical industryFull story -
GSK Bags Tesaro For $5B As It Leaps Back Into Commercial Oncology, Beefs Up Cancer Drug Pipeline
Dec 5, 2018, 10:39 AM by Michael CroftEndpoints News | GlaxoSmithKline has struck a deal to buy Tesaro in a $5.1 billion deal that will vault the pharma giant into the commercial oncology market as it stakes out a big new role for itself in the booming cancer field.Full story -
OmniTier Debuts CompStor Novos Platform For De Novo Assembly-Based Variant Calling
Dec 5, 2018, 09:20 AM by Michael CroftFull storyBio-IT World News Brief | OmniTier has debuted the CompStor Novos platform for de novo assembly-based variant calling in whole genome sequencing applications.
-
Certara Launches BaseCase Toolkits to Facilitate Pharmaceutical and Medical Device Field Teams’ HCP and Payer Presentations
Dec 5, 2018, 08:14 AM by Michael CroftPRINCETON, NJ - Dec 5, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of its BaseCase Toolkits, an add-on to BaseCase Interactive which helps pharmaceutical and medical device field representatives better manage and utilize their resources for use during customer presentationsFull story -
uniQure incorporates novel synthetic promoter developed by Synpromics in new preclinical target
Dec 5, 2018, 05:48 AM by Michael CroftEDINBURGH, UK - Dec 5, 2018 - Synpromics is pleased to hear that its partner, uniQure (NASDAQ:QURE), has announced the incorporation of its promoter, developed by Synpromics, in a new preclinical research targetFull story -
BOC Sciences Recently Updates Its Metabolites and Impurities Collection
Dec 4, 2018, 01:02 AM by Michael CroftLONG ISLAND CITY, NY, UNITED STATES - Dec 4, 2018 - Starting from the year of 2013, BOC Sciences has been providing a wide variety of metabolites and impurities for scientists in the research communityFull story -
Creative Peptides Released Post-translational Modification for Science Community
Dec 4, 2018, 00:58 AM by Michael CroftLONG ISLAND CITY, NY, UNITED STATES - Dec 4, 2018 - Earlier this October, Creative Peptides, one of the worlds leading peptide manufacturers, has announced a series of peptide modification servicesFull story -
TARGET PharmaSolutions® Announces Partnership with Bristol Myers Squibb to Advance Inflammatory Bowel Disease (IBD) Research
Dec 3, 2018, 11:27 AM by Michael CroftCHAPEL HILL, NC, UNITED STATES - Dec 3, 2018 - TARGET PharmaSolutions, Inc., a company focused on real-world evidence, is pleased to announce that Bristol Myers Squibb has entered into a strategic partnership for TARGET-IBDFull story -
Despite CRISPR Baby Controversy, Harvard University Will Begin Gene-Editing Sperm
Nov 30, 2018, 11:22 AM by Michael CroftMIT Technology Review | Even as a furious debate broke out in China over gene-edited babies, some scientists in the US are also hoping to improve tomorrow's children.Full story -
MDI Biological Laboratory Scientist Receives Scientific Innovation Award
Nov 30, 2018, 11:17 AM by Michael CroftBAR HARBOR, ME, UNITED STATES - Nov 30, 2018 - Vicki P. Losick, Ph.D., has been named the inaugural recipient of an award from the William Procter Scientific Innovation FundFull story -
Greenphire Named to Deloitte's 2018 Technology Fast 500™ for Fifth Consecutive Year
Nov 30, 2018, 09:45 AM by Michael CroftKING OF PRUSSIA, PA, UNITED STATES - Nov 27, 2018 - Greenphire, the global leader in financial technology for clinical trials, announced today that it has been ranked as 391 on Deloitte's 2018 Technology Fast 500Full story -
CD Genomics Announces Highly Accurate and Sensitive MicroRNA Expression Profiling Microarray for Conducting a Genome-wide Analysis
Nov 30, 2018, 01:59 AM by Michael CroftSHIRLEY, NY - Nov 30, 2018 - CD Genomics, an expert in transcriptomics and next generation sequencing company, announces the launch of its microRNA expression profiling microarray services, which are based on some of the most powerful platforms in this field with unrivaled accuracy and sensitivityFull story -
Facing Backlash, Chinese Scientist Defends Gene-Editing Research On Babies
Nov 28, 2018, 12:30 PM by Michael CroftNPR.org | He Jiankui, who shocked the world by asserting he had genetically edited twin girls, faced growing criticism from other researchers as he spoke at a scientific conference in Hong Kong.Full story -
UberCloud, The Wellcome Sanger Institute, Panasas, And More: News From November 2018
Nov 28, 2018, 11:35 AM by Michael CroftFull storyBio-IT World | November featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including UberCloud, the Wellcome Sanger Institute, Panasas, and more.
-
Certara Launches Trial Simulator 2.3 to Improve Clinical Trial Success
Nov 28, 2018, 11:14 AM by Michael CroftPRINCETON, NJ - Nov 28, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of version 2Full story -
CanDIG to Power Canadian National Genomics Data Service, CHORD
Nov 27, 2018, 14:45 PM by Michael CroftTORONTO, ON, CANADA - Nov 27, 2018 - Data volumes everywhere are growing rapidly. In genomics — the study of the entirety of genetic information of individuals and populations— new sequencing technologies and techniques are turning this flood into a torrent, and all of that new data holds the promise of delivering new insights into biology, health, and diseaseFull story